2003
|
||
|---|---|---|
|
January
January; 51 (1): 1 - 205 |
February
February; 51 (2): 207 - 477 |
March
March; 51 (3): 479 - 748 |
|
April
April; 51 (4): 749 - 1053 |
May
May; 51 (5): 1055 - 1321 Supplement: Antimicrobial development: quinolones past, present and future Supplement: Linezolid: a novel oxazolidinone antimicrobial for the treatment of serious Gram-positive infections |
June
June; 51 (6): 1323 - 1441 Supplement: Vancomycin resistance in enterococci: a clinical challenge |
|
July
July; 52 (1): 1 - 143 |
August
August; 52 (2): 145 - 317 |
September
September; 52 (3): 319 - 536 |
|
October
October; 52 (4): 537 - 741 |
November
November; 52 (5): 743 - 881 Supplement: Managing skin and soft tissue infections: expert panel recommendations on key decision points |
December
December; 52 (6): 883 - 1050 |